Eflotela 300 mg, 300 mg, 400 mg Tablets

Eflotela 300 mg, 300 mg, 400 mg Tablets

S4
PDF Leaflet Revision Date: 26 September 2023


Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of HIV-1 in adults over 18 years stabilized on similar antiretrovirals.

Dosage (summary)

One tablet daily on an empty stomach; bedtime dosing recommended.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and breastfeeding; barrier contraception advised.

Key Drug Interactions

  • CYP450 inducers/inhibitors
  • St. John's wort
  • Rifampicin

Contraindications

  • Hypersensitivity
  • Severe hepatic impairment
  • Moderate to severe renal impairment

Common side effects

  • Dizziness
  • Nausea
  • Diarrhea
  • Rash

Counselling Points

  • Take on an empty stomach
  • Monitor for liver function
  • Avoid alcohol

Serious warnings

  • Lactic acidosis
  • Severe hepatotoxicity
  • Immune reconstitution inflammatory syndrome
Important Disclaimer

The Eflotela 300 mg, 300 mg, 400 mg Tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites